On the recordFebruary 26, 2014
Our share, U.S. share, of biomedical R&D expenditure declined from 52 percent to 42 percent despite what is happening in the rest of the world.
Source
congress.govEditor's note · Context
DeLauro highlights the decline in U.S. biomedical R&D funding compared to global trends.
Share
More from Rosa DeLauro
Nov 5, 2025
When would you reevaluate budgets? Who would check the executive branch? What if Congress never weighed in?
Jul 30, 2026
“Providers around the county were shocked by what was such an unpredictable action,” DeLauro said, thanking state leaders for leading that outcry in Connecticut.
Other voices in this conversation
